NCT06683729View on ClinicalTrials.gov

HighLife Clarity Treatment of Severe Mitral Regurgitation

NANot yet recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2034

Conditions
Mitral Valve (MV) Regurgitation
Interventions
DEVICE

Trans-septal (TS) Mitral Valve Replacement (TSMVR) Valve system

Trans-catheter, trans-septal mitral valve replacement.

All Listed Sponsors
lead

HighLife SAS

INDUSTRY

NCT06683729 - HighLife Clarity Treatment of Severe Mitral Regurgitation | Biotech Hunter | Biotech Hunter